한글목차

전 세계 유도만능줄기세포(iPSC) 시장 규모는 2023년 34억 달러에서 예측 기간 동안 9.1%의 연평균 복합 성장률(CAGR)을 나타내고, 2028년 말에는 52억 달러 규모로 성장할 것으로 예상됩니다.

비통합법 부문은 2023년 21억 달러에서 2028년 34억 달러에 이르고, 연평균 10.1% 성장할 것으로 예상됩니다. 통합법 부문은 2023년 13억 달러에서 2028년 18억 달러에 이르고, 연평균 7.5% 성장할 것으로 예상됩니다.

세계의 유도만능줄기세포(iPSC) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신기술 및 기술 개발 동향, 임상시험 및 특허 동향, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• 유도만능줄기세포(iPSC) 생성

제3장 시장 역학

• 세계 시장 역학
• 시장 성장 촉진요인
• 만성질환 증가
• 바이오테크놀러지 산업에 대한 투자 증가
• 맞춤형 의료 수요 증가
• 의약품 연구개발에 대한 투자 증가
• 효과적인 의약품 발견과 개발 프로세스에 수요
• 동물 실험 최소화
• 시장 성장 억제요인
• 비싼 개발비와 숙련 노동력 부족
• iPSC 기반 질환 모델, 세포치료, Drug Discovery에 관련된 과제
• 시장 기회
• 기술 진보
• iPSC 뱅킹 성장

제4장 신기술과 개발

• iPSC 연구 진보
• 리프로그래밍 기술
• 유전자 편집 기술
• 3D 오가노이드
• 재생의료
• iPSC 연구 분야의 AI 진화와 현재 응용

제5장 임상시험 분석

• 임상시험

제6장 특허 분석

• 특허 분석

제7장 시장 세분화 분석

• 세분화 내역
• 개요
• iPSC 생성 : 리프로그래밍 방법별 시장 분석
• iPSC 시장 : 생성법 별
• iPSC 시장 : 용도별
• 학술 연구
• 약리 독성 스크리닝
• Drug Discovery & Development
• 질환 모델링
• 조직공학
• 세포치료
• 세계 시장
• iPSC 지역 시장 : 용도별
• iPSC 유래 조직 세포 시장 : 유형별
• 심근세포
• 신경세포
• 내피세포
• 간세포
• 기타 세포
• iPSC 유래 조직 세포 시장 : 유형별
• 세계 시장
• iPSC 유래 조직 세포 시장 : 용도별
• 세계 시장
• iPSC 시장 : 제품 기능별
• 세계 시장
• iPSC 지역 시장 : 제품 기능별
• iPSC 시장 : 최종사용자별
• iPSC 수탁 서비스 유형
• 주요 기업
• 세계 시장
• 지역별 분석
• iPSC 시장 : 지역별
• 미국
• 유럽
• 아시아태평양
• 기타 지역

제8장 경쟁 정보

• 경쟁 구도 : 개요
• 전략 분석
• 합의
• 협업 및 전략적 제휴
• 파트너십
• 신제품 개발·발매
• 확장 및 인수
• 자금조달
• 승인 및 임상시험
• 기타
• 주요 기업 : 제품 유형별

제9장 부록

• 조사 방법
• 약어
• 출전
• 기업 개요
• ATCC
• AXOL BIOSCIENCE LTD.
• BIO-TECHNE
• FUJIFILM CELLULAR DYNAMICS INC.
• LONZA
• MERCK KGAA
• NCARDIA
• QIAGEN
• REPROCELL INC.
• STEMCELL TECHNOLOGIES
• TAKARA BIO INC.
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.

The global market for iPSCs generated by non-integrated method is expected to grow from $2.1 billion in 2023 to reach $3.4 billion by 2028, at a CAGR of 10.1% from 2023 to 2028.

The global market for iPSCs generated by integrated method is expected to grow from $1.3 billion in 2023 to reach $1.8 billion by 2028, at a CAGR of 7.5% from 2023 to 2028.

Report Scope

The scope of this study encompasses an investigation of the market. BCC Research analyzes this market based on application type, product function, generation of iPSC and types of iPSC derived cells and species. Application-based market segments include drug development and toxicity testing, academic research and regenerative medicine. Product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation and cell analysis. iPSC-derived cell-type-based market segments include hepatocytes, neurons, cardiomyocytes, endothelial cells and other cell types. Other cell types include astrocytes, fibroblasts and hematopoietic progenitor cells. BCC Research determines the current market status in each segment, examines its impact on future needs and presents growth forecasts through 2028.

The report also provides a detailed analysis of the market's drivers, restraints, challenges and opportunities. In addition, the report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. it also provides detailed information on this market, emerging technologies and new developments, regulatory landscape, patent analysis, pipeline analysis and investment outlook and deals.

Report Includes

• 28 data tables and 56 additional tables
• An analysis of the global market for induced pluripotent stem cells (iPSCs) or artificial stem cells
• Analyses of global market trends, with market revenue data from 2020 to 2023, and projected CAGRs through 2028
• Estimate of the size and revenue prospects of the global market, along with a market share analysis by reprogramming method, generation method, application, product function, iPSC-derived cell type, species, end use, and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, and the macroeconomic factors that influence the industry
• A Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• Insights into iPSC research activity, emerging technologies, clinical trials and pipeline products
• Patent activity and analysis of recent patent grants/publications
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
• Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
• Profiles of market leaders, including Fujifilm Cellular Dynamics (FCDI) Inc., Axol Bioscience Ltd., Merck KGaA, Thermo Fisher Scientific Inc., and Takara Bio Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Introduction
• Induced Pluripotent Stem Cells (iPSC) Generation

Chapter 3 Market Dynamics

• Global Market Dynamics
• Market Drivers
• Increasing Prevalence of Chronic Diseases
• Increasing Investment in Biotechnology Industry
• Increasing Demand for Personalized Medicines
• Increasing Investments for Drug Research and Development
• Demand for Effective Drug Discovery and Development Process
• Minimizing Animal Testing
• Market Restraints
• High Development Costs and Lack of Skilled Workforce
• Challenges Associated with iPSC-based Disease Modeling, Cell Therapy and Drug Discovery
• Market Opportunities
• Technological Advances
• Growth in iPSC Banking

Chapter 4 Emerging Technologies and Developments

• Advances in the iPSC Research
• Reprogramming Technologies
• Gene Editing Technologies
• 3D Organoids
• Regenerative Medicine
• Evolution and Current Application of Artificial Intelligence (AI) in iPSC Research

Chapter 5 Clinical Trial Analysis

• Clinical Trials

Chapter 6 Patent Analysis

• Patent Analysis

Chapter 7 Market Segmentation Analysis

• Segmentation Breakdown
• Overview
• Generation of Induced Pluripotent Stem Cells -- Market Analysis, by Reprogramming Method
• Market for Induced Pluripotent Stem Cells, by Generation Method
• Market for Induced Pluripotent Stem Cells, by Application
• Academic Research
• Pharmaco-toxicological Screening
• Drug Discovery and Development
• Disease Modeling
• Tissue Engineering
• Cell Therapy
• Global Market
• Regional Markets for iPSCs, by Application
• iPSC-derived Tissue Cell Market, by Type
• Cardiomyocytes
• Neurons
• Endothelial Cells
• Hepatocytes
• Other Cells
• iPSC-derived Tissue Cell Market, by Species
• Global Market
• iPSC-derived Tissue Cell Market, by Application
• Global Market
• Market for Induced Pluripotent Stem Cells, by Product Function
• Global Market
• Regional Markets for iPSCs, by Product Function
• Market for Induced Pluripotent Stem Cells, by End Use
• Induced Pluripotent Stem Cell Contract Service Types
• Major Players
• Global Market
• Geographic Breakdown
• Market for Induced Pluripotent Stem Cells, by Region
• The U.S.
• Europe
• Asia-Pacific
• Rest of the World

Chapter 8 Competitive Intelligence

• Competitive Landscape -- Overview
• Strategic Analysis
• Agreements
• Collaborations & Strategic Alliances
• Partnerships
• New Product Development and Launches
• Expansions and Acquisitions
• Fund Raising
• Approval and Clinical Trials
• Others
• Major Companies in Induced Pluripotent Stem Cells Market, by Type of Offerings

Chapter 9 Appendix

• Methodology
• Abbreviations
• Sources
• Company Profiles
• ATCC
• AXOL BIOSCIENCE LTD.
• BIO-TECHNE
• FUJIFILM CELLULAR DYNAMICS INC.
• LONZA
• MERCK KGAA
• NCARDIA
• QIAGEN
• REPROCELL INC.
• STEMCELL TECHNOLOGIES
• TAKARA BIO INC.
• THERMO FISHER SCIENTIFIC INC.